0      0

2020 uroLogic and Advanced uroLogic - Premier Conference for Urology Professionals


902 - Compounding Formulations for Urologic Conditions


Oct 17, 2020 1:45pm ‐ Oct 17, 2020 3:00pm

Description

After this session, the clinician will walk away with information about compounded preparations as an adjuvant or alternative therapy to what is commercially available, will gain insight of compounded options for patients who have failed traditional therapy, and will broaden their scope of practice with the working knowledge of how, when, and identification of whom to prescribe compounded formulation.

Continuing Education Instructions and Disclosure Information:

Contact hours available until 10/18/22.

Requirements for Successful Completion:

Complete the learning activity in its entirety and complete the online CNE evaluation. You will be able to print your CNE certificate at any time after you complete the evaluation.

Faculty, Planners, and Speakers Conflict of Interest Disclosure:

Planning Committee Disclosures:

Christina Hegan, MS, APRN, WHNP-BC
Spouse is a distributor for CBD rich hemp oil

There are no other Planning Committee disclosures to declare.

Speakers Conflict of Interest Disclosure:
Tara Thompson, PharmD, FIACP
Pharmacist at Innovation Compounding Pharmacy

There are no other speaker disclosures to declare.

Commercial Support and Sponsorship:
No commercial support or sponsorship declared.

Accreditation Statement:
Society of Urologic Nurses and Associates (SUNA) is accredited with distinction as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.

The SUNA accreditation is reciprocal in the states and specialty organizations that recognize the ANCC-COA accreditation process. SUNA is also a provider approved by the California Board of Registered Nursing, Provider Number CEP 5556. Accreditation and approved provider status of CE in nursing does not imply ANCC-COA approval or endorsement of any product, advertising, or educational content. SUNA urges all participants to be aware of the CE requirements for re-licensure in the states in which they hold a license.

Learning Outcome:
After completing this education activity, the learner will be able to attain information about compounded preparations as an adjuvant or alternative therapy to what is commercially available to gain insight of compounded options for patients who have failed traditional therapy.

Speaker(s):

  • Tara Thompson, PharmD, FIACP, Vice President of Clinical Services, Innovation Compounding

You must be logged in and own this session in order to post comments.

Print Certificate
Completed on: token-completed_on
Print Transcript
Please select the appropriate credit type:
/
test_id: 
credits: 
completed on: 
rendered in: 
* - Indicates answer is required.
token-content

token-speaker-name
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
/
/
token-index
token-content
token-index
token-content